REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 252,468 Value ($000) $768 Avg Close — Range —
Q3 2024
Shares 567,300 Value ($000) $2,944 Avg Close — Range —
Q1 2024
Shares 781,223 Value ($000) $3,844 Avg Close — Range —
Q3 2023
Shares 713,638 Value ($000) $8,185 Avg Close — Range —
Q2 2023
Shares 90,528 Value ($000) $2,291 Avg Close — Range —
Q3 2022
Shares 41,253 Value ($000) $1,115 Avg Close — Range —
Q2 2022
Shares 16,858 Value ($000) $233 Avg Close — Range —
Q1 2022
Shares 122,598 Value ($000) $2,391 Avg Close — Range —
Q1 2019
Shares 30,675 Value ($000) $483 Avg Close — Range —